nafld
Gilead acquires Phenex liver disease drugs
January 7, 2015Research and Development, Sales and Marketing Farnesoid X Receptor, Gilead, liver, nafld, nash, phenex
Gilead Sciences has acquired Phenex Pharmaceuticals’ development programme for the treatment of serious liver diseases. The US biopharma firm will …
GE and Takeda make liver pact
November 13, 2014Research and Development, Sales and Marketing GE Healthcare, Japan, Takeda, US, liver, nafld, nash
GE Healthcare and Takeda Pharmaceutical have joined forces to develop treatments which target liver conditions including non-alcoholic fatty liver disease …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
